Prognostic Implications of LV Strain Risk Score in Asymptomatic Patients With Hypertensive Heart Disease ONLINE FIRST

da Calogero Calcullo | Lug 10, 2016 | Cardiologia: presente e futuro... Discutiamone, Novità Dalla letteratura, Rubriche

Abstract Objectives  This study sought to investigate the associations of left ventricular (LV) strain and its serial change with major adverse cardiac events (MACE) in hypertensive heart disease, independent of and incremental to clinical and LV geometric parameters....

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

da Calogero Calcullo | Giu 25, 2016 | Novità Dalla letteratura, Rubriche

Objective To study the effectiveness and safety of the non-vitamin K antagonist oral anticoagulants (novel oral anticoagulants, NOACs) dabigatran, rivaroxaban, and apixaban compared with warfarin in anticoagulant naïve patients with atrial fibrillation....

Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary

da Calogero Calcullo | Giu 23, 2016 | Novità Dalla letteratura, Rubriche

In 2013, the European Heart Rhythm Association (EHRA) published a Practical Guide on the use of non-VKA oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) (Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof...

Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS–TIMI 54

da Calogero Calcullo | Giu 23, 2016 | Novità Dalla letteratura, Rubriche

Background  Patients with diabetes appear to be at elevated risk of atherothrombotic events. Objectives  The purpose of this study was to determine the effect of antiplatelet therapy with ticagrelor on recurrent ischemic events in patients with diabetes and prior...

Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation

da Calogero Calcullo | Giu 23, 2016 | Novità Dalla letteratura, Rubriche

Direct oral anticoagulants (DOACs) have been used in clinical practice in the United States for the last 4 to 6 years. Although DOACs may be an attractive alternative to warfarin in many patients, long-term outcomes of use of these medications are unknown. We...

USO dei NAO

da Antonio Vittorio Panno | Mag 7, 2016 | Rubriche

Abstract :The novel oral anticoagulants or direct oral antico- agulants (DOAC) are becoming more common in clinical practice for the prevention of stroke in non-valvular atrial fibrillation (NVAF). The availability of several agents with similar efficacy and safety...